Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism CA19.9 inhibitors(Carbohydrate antigen 19-9 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CN | 18 Jul 2023 |